12 March 2025
press release
poland
Poland: Schoenherr advises shareholders of Nortec Pharma on sale of majority stake to Frewitt
Schoenherr advised the shareholders of Nortec Pharma on the sale of a majority stake to Frewitt, a Swiss-based leader in milling and processing technologies for the pharmaceutical industry. The transaction expands Frewitt's product range and service offering, reinforcing its position in the market. The value of the transaction remains confidential.
Poland-headquartered Nortec Pharma specialises in pharmaceutical processing solutions. Its acquisition marks a strategic move for both companies to enhance their innovative capabilities and market reach.
Headquartered in Switzerland, Frewitt produces milling and sizing equipment for the pharmaceutical, food and fine chemical industries.
The Schoenherr team advising on the transaction consisted of Tomasz Kwaśniewski (partner), Szymon Okoń (partner), Dawid Brudzisz (counsel) and Witold Oszczanowski (associate).
Tomasz
Kwaśniewski
Partner
poland
press contact
Katharina
Falkner
Corporate Communications & Business Development Manager
austria vienna